分泌生长激素的垂体腺瘤中68Ga-DOTATOC PET/CT、18F-FDOPA与18F-FDG PET/MR表现
68 Ga- DOTATOC PET/CT, 18 F-FDOPA, and 18 F-FDG PET/MR Findings in Growth Hormone-secreting Pituitary Adenoma.
PubMed 文献 · Clin Nucl Med · 2025-06-30
本文报告一例57岁男性因偶然发现胰腺病变行68Ga-DOTATOC PET/CT,显示垂体增大且放射性摄取增高;补充18F-FDOPA与18F-FDG PET/MRI显示鞍区病变提示垂体腺瘤,手术切除后病理证实为分泌生长激素的垂体腺瘤。
要点
- 68Ga-DOTATOC PET/CT在偶然发现胰腺病变时显示垂体增大且摄取增高。
- 18F-FDOPA与18F-FDG PET/MRI显示鞍区病变,提示垂体腺瘤。
- 手术切除肿瘤后病理检查证实为分泌生长激素的垂体腺瘤。
主要发现
- 68Ga-DOTATOC PET/CT显示垂体增大且放射性摄取增高。
- 18F-FDOPA与18F-FDG PET/MRI显示鞍区病变,提示垂体腺瘤。
- 手术切除肿瘤后病理检查证实为分泌生长激素的垂体腺瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acromegaly is a rare disease frequently caused by a growth hormone-secreting pituitary adenoma (GHPA), and neuroimaging plays an important role in tumor localization, characterization, and surgical planning. A 57-year-old man underwent 68 Ga-DOTATOC PET/CT for an incidental pancreatic lesion. The PET revealed an increased radiotracer uptake and enlargement of the pituitary gland. The study was completed with 18 F-FDOPA and 18 F-FDG PET/MRI, which revealed a sellar lesion suggesting pituitary adenoma. Pathological examination of the resected tumor confirmed a GHPA.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Suárez-Piñera M, Castell-Aulet J, Ruiz-Roig N, et al. 68 Ga- DOTATOC PET/CT, 18 F-FDOPA, and 18 F-FDG PET/MR Findings in Growth Hormone-secreting Pituitary Adenoma. Clin Nucl Med. 2025. PMID: 40583178. doi:10.1097/RLU.0000000000005937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。